However, in a mouse model of ulcerative colitis with loss of the intestinal barrier, symptoms have been reported to exacerbate in mice lacking TLR4 of the LPS receptor, and removal of the intestinal microbiota by antibiotic cocktail administration exacerbates ulcerative colitis symptoms, whereas oral LPS administration improves symptoms (103). Here, TLR4 is linked to ulcerative colitis.